ACAD Latest Headlines

Analysts Are Bullish on These Healthcare Stocks: Dyne Therapeutics (DYN), ACADIA Pharmaceuticals (ACAD)

at www.tipranks.com (Tue, 21-Jul 4:41 PM)

Mizuho Securities Sticks to Its Buy Rating for ACADIA Pharmaceuticals (ACAD)

at www.tipranks.com (Tue, 21-Jul 12:26 PM)

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Palvella Therapeutics (PVLA), Neogen (NEOG) and ACADIA Pharmaceuticals (ACAD)

at www.tipranks.com (Tue, 21-Jul 12:21 PM)

Analysts Have Conflicting Sentiments on These Healthcare Companies: Palvella Therapeutics (PVLA), Neogen (NEOG) and ACADIA Pharmaceuticals (ACAD)

at www.tipranks.com (Tue, 21-Jul 12:11 PM)

FDA Fast Track Designation for Remlifanserin Highlights Acadia’s Progress in Alzheimer’s Disease Psychosis

Market Chameleon (Mon, 20-Jul 9:39 AM)

Acadia gains Fast Track status for remlifanserin in Alzheimer's disease psychosis

at seekingalpha.com (Mon, 20-Jul 9:16 AM)

Acadia Pharmaceuticals Welcomes Carl Segerstrom as Chief People Officer to Steer Next Growth Phase

Market Chameleon (Mon, 6-Jul 9:20 AM)

Acadia’s DAYBU Wins Key EU Backing as First Rett Syndrome Neurobehavioral Treatment Awaits Final Approval

Market Chameleon (Fri, 26-Jun 11:46 AM)

DAYBU Receives Positive CHMP Opinion: A Milestone in European Rett Syndrome Treatment

Market Chameleon (Fri, 26-Jun 7:31 AM)